Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Viral vector-based gene therapies in the clinic. | Bioeng Transl Med | 2022 | 35079633 | PubTator, text mining | PubMed |
| NK cells in the brain: implications for brain tumor development and therapy. | Trends Mol Med | 2022 | 35078713 | PubTator, text mining | PubMed |
| Identification of Aging-Related Genes Associated with Prognostic Value and Immune Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma. | Oxid Med Cell Longev | 2022 | 35069971 | PubTator, text mining | PubMed |
| Secreted phosphoprotein 1 as a potential prognostic and immunotherapy biomarker in multiple human cancers. | Bioengineered | 2022 | 35067176 | PubTator, text mining | PubMed |
| Combination strategies with PD-1/PD-L1 blockade: current advances and future directions. | Mol Cancer | 2022 | 35062949 | PubTator, text mining | PubMed |
| A Hot Topic: Cancer Immunotherapy and Natural Killer Cells. | Int J Mol Sci | 2022 | 35054985 | PubTator, text mining | PubMed |
| Early Biomarkers Associated with P53 Signaling for Acute Radiation Injury. | Life (Basel) | 2022 | 35054492 | PubTator, text mining | PubMed |
| Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma. | Cancers (Basel) | 2022 | 35053609 | PubTator, text mining | PubMed |
| The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity. | Cancers (Basel) | 2022 | 35053463 | PubTator, text mining | PubMed |
| HLA-independent T cell receptors for targeting tumors with low antigen density. | Nat Med | 2022 | 35027758 | PubTator, text mining | PubMed |
| Overview of the pre-clinical and clinical studies about the use of CAR-T cell therapy of cancer combined with oncolytic viruses. | World J Surg Oncol | 2022 | 35027068 | PubTator, text mining | PubMed |
| The p53 Pathway Related Genes Predict the Prognosis of Colon Cancer. | Int J Gen Med | 2022 | 35023955 | PubTator, text mining | PubMed |
| N-Glycosylation Facilitates 4-1BB Membrane Localization by Avoiding Its Multimerization. | Cells | 2022 | 35011724 | PubTator, text mining | PubMed |
| Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer. | Int J Biol Sci | 2022 | 35002511 | PubTator, text mining | PubMed |
| Comprehensive analysis of a TNF family based-signature in diffuse gliomas with regard to prognosis and immune significance. | Cell Commun Signal | 2022 | 35000592 | PubTator, text mining | PubMed |
| Off-the-Shelf Prostate Stem Cell Antigen-Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer. | Gastroenterology | 2022 | 34999097 | PubTator, text mining | PubMed |
| In vitro anti-synovial sarcoma effect of diallyl trisulfide and mRNA profiling. | Gene | 2022 | 34995734 | PubTator, text mining | PubMed |
| Predicting the targets of IRF8 and NFATc1 during osteoclast differentiation using the machine learning method framework cTAP. | BMC Genomics | 2022 | 34991467 | PubTator, text mining | PubMed |
| Deconvolving Clinically Relevant Cellular Immune Cross-talk from Bulk Gene Expression Using CODEFACS and LIRICS Stratifies Patients with Melanoma to Anti-PD-1 Therapy. | Cancer Discov | 2022 | 34983745 | PubTator, text mining | PubMed |
| The role of mesenchymal stem cells in the occurrence, development, and therapy of hepatocellular carcinoma. | Cancer Med | 2022 | 34981659 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=55